ZTS Zoetis Inc.
ZTS Zoetis Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
Market read
Scan convergence 2 scans as of 2026-10-16 1 bear 1 neutral converging
POC $77.05 · VWAP $98.08 · -19.1% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 related campaign
ZTS Price Structure
Loading timeframes…
Peers
Every watchlist ZTS belongs to, members best 30-day change first — ZTS highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@livestock-disease
@healthcare
Reported the quarter ending 2026-06-30: revenue $2.47B, diluted EPS $1.65, net income $691M (SEC filing). Across the print the stock moved -2.3% (close before → first close after).
full note →Against street estimates
How ZTS's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
Recent news
Headlines about ZTS from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 8 days ago · Oct 9
- Zoetis - Zoetis Announces Second Quarter 2026 Results
- Zoetis Inc. (ZTS) Q2 FY2026 earnings call transcript
- Zoetis Inc (ZTS) (Q2 2026) Earnings Call Highlights: Navigating Market Headwinds with Strategic ...
- Zoetis Inc. (ZTS) stock price, news, quote and history - Yahoo Finance
- Zoetis Announces First Quarter 2026 Results
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
ZTS research tape
39 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.